Search

Your search keyword '"Crespo, G."' showing total 759 results

Search Constraints

Start Over You searched for: Author "Crespo, G." Remove constraint Author: "Crespo, G."
759 results on '"Crespo, G."'

Search Results

1. Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

2. METODOLOGÍA MIXTA

5. Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types

8. Efecto de tres tipos de estiramiento en la elasticidad de musculatura isquiotibial. Ensayo clínico aleatorizado.

9. Global multi-stakeholder endorsement of the MAFLD definition

10. Análisis general de estabilidad de los puentes sector La Concordia

12. Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program

13. Why do we need an urban health agenda that prioritizes children and adolescents in Latin America?

15. 848P Second-line systemic treatment for patients with advanced melanoma: Results from the prospective real-world study GEM1801

16. 802P Demography and clinical outcomes of adjuvant therapy in Spain: Results from GEM 1801 study

17. 837P Real-world evidence of encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma in Spain (GEM 2002 - BECARE)

18. 863P Elderly patients (pts) with advanced melanoma: Results from the prospective real-world study GEM1801

19. Nicht-invasive Tests für klinisch signifikante portale Hypertension nach Heilung der Hepatitis C–gepoolte Analyse und Validierung der prognostischen Wertigkeit

20. Efficacy of a multispecialty, multidisciplinary strategy to improve the level of awareness and control of cardiovascular risk factors after liver transplantation

21. Magnetizing lead-free halide double perovskites

26. Initial Clinical and Treatment Patterns of Advanced Differentiated Thyroid Cancer. ERUDIT Study

36. Propiedades químicas, color y humectabilidad de partículas de Laureliopsis philippiana (TEPA) con y sin tratamiento térmico

38. 1107P Durvalumab plus tremelimumab in patients with grade 3 neuroendocrine neoplasms of gastroenteropancreatic origin: Updated results from the multicenter phase II DUNE trial (GETNE 1601)

39. 1099MO Durvalumab plus tremelimumab influence on response to subsequent treatments in patients with neuroendocrine neoplasms (NENs) of gastroenteropancreatic and lung origins: Results from the phase II DUNE trial (GETNE 1601)

40. 1097O The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs

41. Author response to: Comment on: Patterns of acute surgical inflammatory processes presentation of in the COVID-19 outbreak (PIACO Study): surgery may be the best treatment option

42. Durvalumab plus tremelimumab influence on response to subsequent treatments in patients with neuroendocrine neoplasms (NENs) of gastroenteropancreatic and lung origins: Results from the phase II DUNE trial (GETNE 1601)

44. Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice

45. Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS)

46. La clase invertida: el papel de las actividades previas en el rendimiento final del alumno

47. 1174P Sex differences in advanced melanoma in Spain: Results from the prospective real-world study GEM 1801

48. 1159P Characterization of melanoma of unknown primary in the era of immunotherapy and targeted therapy in Spain: Results from the prospective real-world study GEM 1801

49. 1114P Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, real-world evidence in Spain (GEM 2002 - BECARE)

Catalog

Books, media, physical & digital resources